Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

- PMLiVE

Pfizer and Astellas’ Xtandi approved by FDA for earlier prostate cancer indication

Xtandi is the first androgen receptor signalling inhibitor approved for this patient population

Can Cinderella save us?

World AMR Awareness Week to focus on urgent actions needed to prevent AMR

AMR has been designated by WHO as one of the top ten threats to global public health

- PMLiVE

Merck receives FDA approval for Keytruda combination in gastric cancer

An estimated 26,500 people in the US will be diagnosed with gastric cancer in 2023

- PMLiVE

Almirall granted EC approval for Ebglyss in moderate-to-severe atopic dermatitis

The inflammatory skin disease currently affects an estimated 4.4% of adults in the EU

- PMLiVE

Pharma AI: how sales and marketing are starting to step out of R&D’s shadow

Traditionally R&D’s province, the meteoric rise of AI has turbo-charged discussions about how commercial organisations can make use of artificial intelligence

- PMLiVE

Therapy Watch launches new tracker covering Postpartum Depression

The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry

Inizio

Hear from her: Message from the Women in Medicine Summit “Be the Change you Want to See”

Medscape Education

Hear from her: Changing what’s possible for Women in Healthcare

Medscape Education

Hear from her: Meet your hosts

Every day, women leaders are changing the healthcare landscape for the better. Our Women in Healthcare Leadership Podcast Series features some of the women working to elevate equity, achieve gender...

Medscape Education

- PMLiVE

MHRA extends licence of Vertex’s cystic fibrosis drugs for young children

Kaftrio and Kalydeco are now approved for use in certain patients aged two to five years

- PMLiVE

AstraZeneca’s Truqap plus Faslodex receives FDA approval for advanced breast cancer

About 290,000 people in the US will be diagnosed with breast cancer in 2023

- PMLiVE

National surveillance data reveals increase in antibiotic resistant infections in England

The number of deaths due to severe antibiotic resistant infections also increased in 2022

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links